An Experimental Weight-Loss Drug Cut Osteoarthritis Pain in Half for Nearly 7 in 10 Patients. The Biggest Question Remains Unanswered

Two critical phase 3 trials conducted by researchers at Northwestern University found that high doses of a new drug had an unexpected benefit.